Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1998
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263819A1 Insecticidal protein toxins from photorhabdus
03/05/1998CA2263791A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/04/1998EP0826964A2 Determination of protein
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826772A2 Human mucin (MUC8)
03/04/1998EP0826696A1 Use of bi-and trispecific antibodies for inducing tumor immunity
03/04/1998EP0826695A1 Destruction of contaminating tumor cells in stem cell transplants by use of bispecific antibodies
03/04/1998EP0826151A1 Method and device for diagnosing and distinguishing chest pain in early onset thereof
03/04/1998EP0826056A2 Stable variant hk2 polypeptide
03/04/1998EP0826053A1 H. INFLUENZAE HxuB AND HxuC GENES, PROTEINS AND METHODS OF USE
03/04/1998EP0826049A1 Human interferon tau compositions and methods of use
03/04/1998EP0826048A1 Pancreas-derived serpin
03/04/1998EP0826045A1 Nucleic acids for treating obesity
03/04/1998EP0826044A1 Bmp-15 compositions
03/04/1998EP0826042A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0826039A1 Method of inhibiting the activity of an intracellular constituent
03/04/1998EP0826033A1 Ataxia-telangiectasia gene
03/04/1998EP0826031A1 Ataxia-telangiectasia gene and its genomic organization
03/04/1998EP0826006A1 Transeptithelial transport of molecular species
03/04/1998EP0826005A1 Avian, vitellin antibodies directed against hiv antigens
03/04/1998EP0825998A1 Preparation of immunoglobulin
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825811A1 Non-genetically modified mammal as a model for multiple sclerosis
03/04/1998EP0656121B1 Method for diagnosing and monitoring sepsis
03/04/1998EP0644948B1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor
03/04/1998EP0542949B1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175262A Novel receptor
03/04/1998CN1175214A Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
03/03/1998US5723585 Method of purifying cardiac hypertrophy factor
03/03/1998US5723583 Antibody containing sialyl lewis X determinants
03/03/1998US5723582 Immunology and autoimmune diseases
03/03/1998US5723581 Murine and human box-dependent myc-interacting protein (Bin1)
03/03/1998US5723437 Glycoproteins and cell surfaces and scavenger receptors
03/03/1998US5723343 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
03/03/1998US5723313 ARF-p19, a novel regulator of the mammalian cell cycle
03/03/1998US5723306 Monoclonal antibodies for the detection of pyrethroids and a process for their production
03/03/1998US5723299 Somatostatin receptors
03/03/1998US5723129 GnRH-leukotoxin chimeras
03/03/1998US5723127 Cancer therapy, vaccines; cell-mediated immune response enhancers
03/03/1998US5723126 Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody
03/03/1998US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
03/03/1998US5723115 Inhibition of adipose tissue development and obesity
02/1998
02/26/1998WO1998008098A2 Assaying d-amino acids in body fluids
02/26/1998WO1998008090A1 Anti-idiotypic antibodies to an epiglycanin
02/26/1998WO1998007881A1 T1 receptor-like ligand i
02/26/1998WO1998007880A1 Human endokine alpha
02/26/1998WO1998007857A1 Reagents and methods useful for detecting diseases of the breast
02/26/1998WO1998007836A1 Manipulation of proanthocyanidin biosynthesis
02/26/1998WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998WO1998007817A1 Detergent compositions comprising antibody controlled lipolytic activity
02/26/1998WO1998007754A1 T1 receptor-like ligand ii
02/26/1998WO1998007753A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
02/26/1998WO1998007750A1 Novel osteopontin derived chemotactic peptides and methods of use
02/26/1998WO1998007738A1 Immunoglobulin trans-spliced transcripts and uses thereof
02/26/1998WO1998007737A1 Method for determining expression of aberrant forms of apc protein
02/26/1998WO1998007736A1 Don-1 gene and polypeptides and uses therefor
02/26/1998WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
02/26/1998WO1998007320A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM)
02/26/1998WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/26/1998WO1997043437A3 Isopentenyl pyrophosphate isomerase (ipi) and/or prenyl transferase inhibitors
02/26/1998WO1997029199A3 Prostate specific antigen peptides and uses thereof
02/26/1998DE19649207C1 Nucleic acid characteristic of late or early passage cells immortalised by papilloma virus
02/26/1998DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein
02/26/1998CA2264201A1 Manipulation of proanthocyanidin biosynthesis
02/26/1998CA2264200A1 Human endokine alpha
02/26/1998CA2264054A1 Method for determining expression of aberrant forms of apc protein
02/26/1998CA2263942A1 Novel osteopontin derived chemotactic peptides and methods of use
02/26/1998CA2263894A1 Novel human growth factors
02/26/1998CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998CA2263854A1 Don-1 gene and polypeptides and uses therefor
02/26/1998CA2263832A1 T1 receptor-like ligand ii
02/26/1998CA2263830A1 T1 receptor-like ligand i
02/26/1998CA2263141A1 Neutralization-sensitive epitopes of cryptosporidium parvum
02/26/1998CA2232239A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
02/25/1998EP0825442A2 Morphogenic protein screening method
02/25/1998EP0825259A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
02/25/1998EP0825256A2 Hybrid cell and its use for the preparation of a drug for the induction of tumourimmunity
02/25/1998EP0824594A1 Improved methods for transfecting t cells
02/25/1998CN1174575A Antithrombotic agent and anti-von willebrand factor monoclonal antibodies
02/25/1998CN1174559A Major outer membrane protein CD of Moraxella
02/24/1998US5721367 Homologous recombination in mammalian cells
02/24/1998US5721351 Compositions and methods for the treatment and diagnosis of immune disorders
02/24/1998US5721349 Genetically altered mutant strain
02/24/1998US5721348 DNA encoding PH-20 proteins
02/24/1998US5721341 Derivatives of nucleosides, processes for the production of these derivatives of nucleosides and specific polyclonal and monoclonal antibodies of these derivatives
02/24/1998US5721339 For identifying and quantifying native antigens on pathogenic bacteria in clinical specimens
02/24/1998US5721337 Human thymosin β15
02/24/1998US5721211 Compositions and methods for treating small cell and nonsmall cell lung cancers
02/24/1998US5721137 Stable synthetic promoter which controlls expression of a heterologous gene in escherichia and bacillus
02/24/1998US5721130 Monitoring alzheimer's disease
02/24/1998US5721122 Obtaining lymphocytes
02/24/1998US5721119 Nucleic acid sequences
02/24/1998US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis
02/24/1998US5721107 Antibodies to G protein coupled glutamate receptors
02/24/1998US5721095 HIV-1/HIV-2 viral detection kit and method
02/24/1998US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor
1 ... 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 ... 1494